ARCHIVES

Cancer Groups Propose Six Characteristics Of Next FDA Head.

This article is from The Cancer Letter archive.

Vol. 34 No. 46 | December 19, 2008

Download PDF Visit The Full Archive

Related Articles

ACCC Asks More Community Representation, Clear Separation From Centers In New NCI Division

June 29, 1979

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007

British Award 100,000 Pounds A Year To UICC

January 11, 1980

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

June 17, 1988